Real-World Safety Outcomes with Brolucizumab in Neovascular Age-Related Macular Degeneration: Findings from the IRIS® Registry
Brolucizumab治疗新生血管性年龄相关性黄斑变性的真实世界安全性结果：来自IRIS®注册研究的发现
期刊:Ophthalmology and Therapy
影响因子:3.2
doi:10.1007/s40123-024-00920-3
Zarbin, Marco A; MacCumber, Mathew W; Karcher, Helene; Adiguzel, Eser; Mayhook, Andrew; LaPrise, Andrew; Bilano, Ver L; Igwe, Franklin; Ip, Michael S; Wykoff, Charles C
